| |
LNG-IUS (N = 209)
|
|---|
|
Study arm
| |
|
Cohort
|
87 (42%)
|
|
RCT
|
122 (58%)
|
|
Age (mean ± SD)
|
44.7 ± 4.8
|
|
Age ≤ 45
|
97 (46%)
|
|
Age > 45
|
112 (54%)
|
|
BMI (mean ± SD)
|
27.4 ± 5.6
|
|
BMI < 25
|
58 (39%)
|
|
BMI ≥ 25
|
91 (61%)
|
|
Previous vaginal delivery
|
159 (81%)
|
|
Previous caesarean section
|
34 (17%)
|
|
Previous polypectomy/ myomectomy
|
13 (6.3%)
|
|
Tubal ligation
|
5 (2.4%)
|
|
Previous LNG-IUS*
|
19 (9.3%)
|
|
Previous treatment HMB†
|
100 (48%)
|
|
Non-hormonal treatment
|
33 (16%)
|
|
Hormonal treatment
|
81 (39%)
|
|
Anticoagulants
|
10 (4.8%)
|
|
Dysmenorrhea
|
139 (71%)
|
|
Mild
|
36 (18%)
|
|
Moderate
|
59 (30%)
|
|
Severe
|
44 (22%)
|
|
PBAC-score (median-IQR)
|
425 (288–744)
|
|
Bleeding days (median-IQR)
|
8 (6–11)
|
- LNG-IUS, levonorgestrel releasing intrauterine system; BMI, Body Mass Index; HMB, heavy menstrual bleeding; PBAC, Pictorial Blood Assessment Chart. Data are presented as number of women (%) unless otherwise indicated
- *Indication for treatment: contraception and/or HMB
- †Women could have received ≥ one previous treatment
